XML 81 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative-effect adjustment on the change in accounting for share-based payments
Common Stock
Additional Paid In Capital
Retained Earnings
Retained Earnings
Cumulative-effect adjustment on the change in accounting for share-based payments
Unearned ESOP Shares
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2019     17,984,105          
Beginning balance at Jun. 30, 2019 $ 408,896   $ 180 $ 190,315 $ 224,545   $ (6,877) $ 733
Increase (Decrease) in Stockholders' Equity                
Net income 22,783       22,783      
Cash dividends declared on common stock, $0.35/common share (4,552)       (4,552)      
Common stock repurchased (in shares)     (1,114,094)          
Common stock repurchased (24,484)   $ (12) (24,472)        
Forfeited restricted stock (in shares)     (3,400)          
Retired stock (in shares)     (8,474)          
Retired stock $ (222)     (222)        
Granted restricted stock (in shares) 56,306              
Exercised stock options (in shares)     106,914          
Exercised stock options $ 1,541   $ 2 1,539        
Share-based compensation expense 1,822     1,822        
ESOP compensation expense 1,195     666     529  
Other comprehensive income 1,284             1,284
Ending balance, shares (in shares) at Jun. 30, 2020     17,021,357          
Ending balance at Jun. 30, 2020 408,263 $ (13,358) $ 170 169,648 242,776 $ (13,358) (6,348) 2,017
Increase (Decrease) in Stockholders' Equity                
Net income 15,675       15,675      
Cash dividends declared on common stock, $0.35/common share (5,018)       (5,018)      
Common stock repurchased (in shares)     (733,347)          
Common stock repurchased (16,155)   $ (8) (16,147)        
Forfeited restricted stock (in shares)     (6,575)          
Retired stock (in shares)     (9,106)          
Retired stock $ (204)     (204)        
Granted restricted stock (in shares) 45,260              
Exercised stock options (in shares)     318,894          
Exercised stock options $ 4,592   $ 5 4,587        
Share-based compensation expense 2,102     2,102        
ESOP compensation expense 1,125     596     529  
Other comprehensive income $ (503)             (503)
Ending balance, shares (in shares) at Jun. 30, 2021 16,636,483   16,636,483          
Ending balance at Jun. 30, 2021 $ 396,519   $ 167 160,582 240,075   (5,819) 1,514
Increase (Decrease) in Stockholders' Equity                
Net income 35,653       35,653      
Cash dividends declared on common stock, $0.35/common share (5,452)       (5,452)      
Common stock repurchased (in shares)     (1,482,959)          
Common stock repurchased (43,348)   $ (15) (43,333)        
Forfeited restricted stock (in shares)     (13,600)          
Retired stock (in shares)     (11,335)          
Retired stock $ (345)     (345)        
Granted restricted stock (in shares) 42,123              
Exercised stock options (in shares)     413,636          
Exercised stock options $ 6,081   $ 4 6,077        
Share-based compensation expense 2,152     2,152        
ESOP compensation expense 1,502     973     529  
Other comprehensive income $ (3,917)             (3,917)
Ending balance, shares (in shares) at Jun. 30, 2022 15,591,466   15,591,466          
Ending balance at Jun. 30, 2022 $ 388,845   $ 156 $ 126,106 $ 270,276   $ (5,290) $ (2,403)